On Invalid Date, Soleno Therapeutics (NASDAQ: SLNO) reported Q2 2023 earnings per share (EPS) of -$0.81, up 12.5% year over year. Total Soleno Therapeutics earnings for the quarter were -$8.48 million. In the same quarter last year, Soleno Therapeutics's earnings per share (EPS) was -$0.72.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.